CoV Biotechnology
Biotechnology Research
Singapore, Central Singapore, Sg
6 employees
- Employees
- 6
CoV Biotechnology Overview
- Headquarters
- Singapore, Central Singapore, Sg
- Website
- www.covbiotech.com
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2022
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About CoV Biotechnology
CoV Biotechnology is an early-stage Singapore-based biotechnology company focusing on inducing broad, pan-sarbecovirus immune responses to address the evolving and mutating nature of the coronavirus. The company is developing booster vaccines and therapeutics that are effective against variants of SARS-2 beta coronavirus, to protect against future variants and future crossovers of related coronaviruses from animal to humans.
Compare Similar Companies to CoV Biotechnology
Leyden Labs
Biotechnology Research
Polaris Partners
Venture Capital And Private Equity Principals
Veredus Laboratories
Biotechnology
Engine Biosciences
Biotechnology Research
ClavystBio
Investment Management
i-DNA Biotechnology Pte Ltd
Biotechnology Research
Automera
Biotechnology Research
ChemT Biotechnology
Biotechnology Research
Biteback Biotechnology Pte. Ltd
Biotechnology
Straits Biotech Pte Ltd
Biotechnology Research